Please select the option that best describes you:
When would you consider metastastectomy of liver lesions in metastatic pancreatic cancer who achieve a favorable response to mFOLFIRINOX?
If you do employ this strategy, are there a number of liver lesions (eg <4) or duration of response that guide your decision making?